PARPi-FL - a Fluorescent PARP1 Inhibitor for Glioblastoma Imaging
New intravital optical imaging technologies have revolutionized our understanding of mammalian biology and continue to evolve rapidly. However, there are only a limited number of imaging probes available to date. In this study, we investigated in mouse models of glioblastoma whether a fluorescent sm...
Main Authors: | Christopher P. Irwin, Yasiri Portorreal, Christian Brand, Yachao Zhang, Pooja Desai, Beatriz Salinas, Wolfgang A. Weber, Thomas Reiner |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-05-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558614000591 |
Similar Items
-
First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis
by: Alistair McLaren, et al.
Published: (2021-08-01) -
PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
by: Ramya Ambur Sankaranarayana, et al.
Published: (2022-09-01) -
Correction: PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer
by: Ramya Ambur Sankaranarayanan, et al.
Published: (2023-02-01) -
Correction Notice for “First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis” by McLaren et al
Published: (2021-08-01) -
[18F]PARPi Imaging Is Not Affected by HPV Status In Vitro
by: Navjot Guru, et al.
Published: (2021-01-01)